J Korean Med Assoc.  2004 Apr;47(4):309-314. 10.5124/jkma.2004.47.4.309.

Treatment of Obese Binge Eater

• Lee JH

• KMID: 2183458
• DOI: http://doi.org/10.5124/jkma.2004.47.4.309

Abstract

It is now widely recognized that there is a subgroup of obese individuals with a significantly disordered eating behavior characterized by binge eating and psychosocial impairment. Many therapeutic approaches for the treatment of obese binge eaters including cognitivebehavioral therapy, treatment of obesity, nutritional counseling, psychoeducation, psychotherapy, motivation enhancement therapy, and medication have their own benefits. Treatment programs for obesity and eating disorders (binge eater, bulimia) have tended to adopt very different approaches to the eating behavior (dieting vs cessation of dieting) and body image (weight loss vs accepting one's current weight). Despite these differences, eating disorders, obesity, and unhealthy weight loss practices have a number of shared personal, socioenvironmental, and behavioral problems. It is important to integrate the treatment approaches to the spectrum of problems related to eating and weight (eating disorders, obesity, and unhealthy weight loss practices).

Keyword

Binge eating; Obesity; Integration

MeSH Terms

Body Image
Bulimia
Counseling
Eating
Feeding and Eating Disorders
Feeding Behavior
Humans
Motivation
Obesity
Psychotherapy
Weight Loss

Reference

1. Lori MI, Dianne NS. Integrating of prevention of eating disorder and obesity: feasible or futile? Preventive Medicine. 2002. 34:299–309.

2. Stunkard AJ. Eating patters and obesity. Psychiatr Q. 1959. 33:284–292.

3. Spitzer RL, Devlin MJ, Walsh BT, Hasin D, Wing RR, Nonas C, et al. Binge eating disorder: A multisite field trial of the diagnostic criteria. Int J Eat Disord. 1992. 11:191–203.

4. de Zwaan M, Mitchell JE, Raymond NC, Spitzer RL. Binge eating disorder: Clinical features and treatment of a new diagnosis. Harv Rev Psychiatry. 1994. 1:310–325.

5. Yanovski SZ, Spitzer RL. Binge eating disorder is associated with psychiatric comorbidity in the obese. Am J Psychiatry. 1993. 150:1472–1479.

6. Marcus MD. Brownell KD, Fairburn CG, editors. Binge eating and obesity. eating disorders and obesity. 1995. New York: The Guilford Press;441–444.

7. Garner DM, Olmsted MP, Davis R, Rockert W, Goldbloom D, Eagle M. The association between bulimic symptoms and reported psychopathology. Int J Eat Disord. 1990. 9:1–15.

8. Ranson KM, Kaye WH, Weltzin TE, Rao R, Matsunaga H. Obsessive-compulsive disorder symptoms before and after recovery from bulimia nervosa. Am J Psychiatry. 1999. 156:1703–1708.

9. Anderson AE, Bowers W, Watson T. A slimming program for ED NOS: Reconceptualizing a confusing residual diagnosis category. Psychiatr Clin North Am. (in press).

10. Robin FA, Agras WS. Overcoming eating disorders: A cognitive-behavioral treatment for bulimia nervosa and binge-eating disorder. 1998. 1–20.

11. Wiiliam RM, Stephen R. Motivational interviewing: Preparing people for change. 2002. 2nd ed. New York: The Guilford Press;201–206.

12. Agras WS, Scott JC, Katherine AH, James EM, Terence WG, Helena CK. Outcome predictors for the cognitie behavioral treatment of bulimia nervosa: data from a multisite study. Am J Psychiatry. 2000. 157:1302–1308.

13. Fairburn CG, Kirk J, O'Connor M. A comparison of two psychological treatment for bulimia nervosa. Behav Res Ther. 1986. 24:629–643.

14. Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebo-controlled, double-blind trial. Arch Gen Psychiatry. 1992. 49:139–147.

15. Susan LM, Leah SC, Eric BN, Kathleen AL, Cesar AS, James IH, et al. Placebo-controlled trial of sertraline in the treatment of binge eating disorder. Am J Psychiatry. 2000. 157:1004–1006.

16. James IH, Susan LM, Nancy CR, Scott C, Paul EK, Jeffrey MJ, et al. Fluvoxamine in the treatment of binge-eating disorder: A multicenter placebo-controlled double-blind trial. Am J Psychiatry. 1998. 155:1756–1762.

17. Neumeister A, Winkler A, Wöber-Bingöl C. Addition of naltrexone to fluoxetine in the treatment of binge eating disorder. Am J Psychiatry. 1999. 156:797.

18. Steven JR, Katherin AH, Neena PS, Stephanie CK, Jalia SL. A placebo-controlled study of fluoxetine in controlled treatment of bulimia nervosa after successful acute fluoxetine treatment. Am J Psychiatry. 2002. 159:96–102.